Glenn Short
InvestorChief Scientific Officer at atai Life Sciences
Boston, Massachusetts, United States
Find your path to Glenn
268 people in our graph share verified history with Glenn β schools, employers, funds. One of them is your warm intro.
About
Glenn Short is Chief Scientific Officer at atai Life Sciences, a role he took in 2025 after serving as Senior Vice President of Early Development from 2022. He leads internal innovation and early-stage product development, integrating translational medicine into development and clinical strategies, and has over 20 years of industry and research experience across venture-backed and public companies. He holds a Ph.D. in Chemistry from the University of Virginia and completed postdoctoral training in molecular biology at Massachusetts General Hospital/Harvard Medical School.
Experience
- Viridia Life SciencesBoard Member2022 β 2023
- Viridia Life SciencesChief Executive Officer2020 β 2022
- EmpathBioBoard Member2022 β 2023
- EmpathBioChief Executive Officer2020 β 2022
- EntheogeniX BiosciencesChief Executive Officer2022 β 2023
- EntheogeniX BiosciencesChief Scientific Officer2019 β 2022
- Glenn Short ConsultingSenior Biotech and Pharmaceutical R&D Consultant2019
- Axial Biotherapeutics, Inc.VP, Early Development2019
- Flex PharmaVP level, Pharmaceutical R&D Consultant2018 β 2019
- Flex PharmaVP, Research and Translational Development2017 β 2018
- Flex PharmaVP, Nonclinical and Translational Research2017
- Flex PharmaSenior Director, Research2014 β 2017
- BiotechnologyBiotechnology Consultant2014
- Zalicus IncorporatedSenior Director, Research2012 β 2013cambridge, ma
- Zalicus IncorporatedDirector of Discovery Sciences2009 β 2012Cambridge, MA
- CombinatoRx, Inc.Team Leader in Discovery Biology2007 β 2009Cambridge, MA
- CombinatoRx, Inc.Senior Scientist in Platform/Technology Development2005 β 2007Cambridge, MA
- Massachusetts General HospitalAssociate Biologist2002 β 2005
- Harvard Medical SchoolHoward Hughes Postdoctoral Scientist in Molecular Biology1999 β 2002Department of Molecular Biology, Massachusetts General Hospital
Skills & more
+12 more
Medicinal ChemistryMolecular ModelingHigh Throughput ScreeningMolecular OncologyChemical GenomicsResearch Program ManagementVirtual Program ManagementResearch ProjectsCommunicationGenomicsAssay DevelopmentBiotechnologyFrom Glenn's professional profile.
Colleagues at atai Life Sciences
Frequently asked questions
- Who is Glenn Short?
- Glenn Short is Chief Scientific Officer at atai Life Sciences, a role he took in 2025 after serving as Senior Vice President of Early Development from 2022. He leads internal innovation and early-stage product development, integrating translational medicine into development and clinical strategies, and has over 20 years of industry and research experience across venture-backed and public companies. He holds a Ph.D. in Chemistry from the University of Virginia and completed postdoctoral training in molecular biology at Massachusetts General Hospital/Harvard Medical School.
- Where does Glenn Short work?
- Glenn Short is Chief Scientific Officer at atai Life Sciences.
- Where did Glenn Short go to school?
- Glenn Short studied at University of Virginia (PhD, Chemistry); University of Virginia (BA, Chemistry).
Same school
Also attended University of Virginia667
+ 661 more
Shared employers
Also worked at Axial Biotherapeutics, Inc.6
Also worked at Flex Pharma1
Also worked at Massachusetts General Hospital102
+ 96 more
Also worked at Harvard Medical School273
+ 267 more

































